Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes (ASTI)
This study has been completed.
Sponsor:
Société de Formation Thérapeutique du Généraliste
Information provided by:
Société de Formation Thérapeutique du Généraliste
ClinicalTrials.gov Identifier:
NCT00398944
First received: November 13, 2006
Last updated: July 26, 2010
Last verified: November 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose is to determine wether an electronic decision support system based on national guidelines is effective to improve the follow-up and the treatment of two conditions: hypertension and diabetes, in primary care practices.
| Condition | Intervention |
|---|---|
|
Diabetes Mellitus Hypertension |
Device: Evaluation of the impact of a guideline based computerized decision support system. |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care |
Resource links provided by NLM:
Further study details as provided by Société de Formation Thérapeutique du Généraliste:
Primary Outcome Measures:
- Patients who underwent the recommended procedures during the last 12 months [ Time Frame: 16 months ] [ Designated as safety issue: No ]
| Enrollment: | 2715 |
| Study Start Date: | November 2006 |
| Study Completion Date: | May 2008 |
| Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |
Existing computer-based ordering systems for physicians provide drug-centred checks but offer little assistance for optimizing the overall patient-centred treatment strategy.
The ASTI project aims :
to design a guideline-based decision support system for diabetic and/or hypertensive patients, to help general practitioners :
- to carry out procedures (clinical and biological tests) according to guidelines (the recommended procedure at the recommended moment), and to get a synthetic view of all the elements they need to follow-up the patient
- to avoid prescription errors and to improve compliance with therapeutic guidelines. The " critic mode " operates as a background process and corrects the physician's prescription on the basis of automatically triggered elementary rules that account for isolated guideline recommendations. The " guided mode " directs the physician to the best treatment by browsing a comprehensive guideline knowledge base represented as a decision tree.
- To measure the impact of ASTI when it is implemented with an electronic medical record system. We adopt a randomized design, with the practice as the unit of randomization.
Eligibility| Ages Eligible for Study: | 25 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Hypertension
- Mellitus diabetes
- Follow-up by GP's
Contacts and Locations
More Information
Publications:
| Responsible Party: | Doctor Hector Falcoff, Société de Formation Thérapeutique du Généraliste |
| ClinicalTrials.gov Identifier: | NCT00398944 History of Changes |
| Other Study ID Numbers: | SFTG1968A |
| Study First Received: | November 13, 2006 |
| Last Updated: | July 26, 2010 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Société de Formation Thérapeutique du Généraliste:
|
Guideline based decision support system, Hypertension, Diabetes |
Additional relevant MeSH terms:
|
Diabetes Mellitus Hypertension Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013